GODDYN supports Celyad
GODDYN starts a collaboration with Celyad for supporting the development of Celyad’s legal strategy and for the provision of legal services.
Celyad SA (Euronext Brussels and Paris, and NASDAQ: CYAD) is a biopharmaceutical company, specialized in cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis. Celyad’s scientific approach is inspired by the natural mechanisms that are used by the body to fight disease. Celyad was founded in 2007 and is based in Mont-Saint-Guibert, Belgium, and Boston, Massachusetts.
Bart GODDYN (as permanent representative of GODDYN BVBA) will cover a broad range of legal matters relevant to the biotech industry with a special focus on transactional and advisory work for Celyad’s R&D, clinical, manufacturing, regulatory, and business development activities.